Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 393

1.

Author Correction: Reciprocal space imaging of ionic correlations in intercalation compounds.

Krogstad MJ, Rosenkranz S, Wozniak JM, Jennings G, Ruff JPC, Vaughey JT, Osborn R.

Nat Mater. 2019 Oct 30. doi: 10.1038/s41563-019-0545-7. [Epub ahead of print]

PMID:
31666686
2.

Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with HIV-1 and hepatitis C virus co-infection: AIDS Clinical Trials Group Sub-Study A5334s.

Venuto CS, Cramer YS, Rosenkranz SL, Sulkowski M, Wyles DL, Cohen DE, Schmidt J, Alston-Smith BL, Morse GD.

Br J Clin Pharmacol. 2019 Oct 27. doi: 10.1111/bcp.14148. [Epub ahead of print]

PMID:
31656054
3.

Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: Results from the AMBITION trial.

McLaughlin VV, Vachiery JL, Oudiz RJ, Rosenkranz S, Galiè N, Barberà JA, Frost AE, Ghofrani HA, Peacock AJ, Simonneau G, Rubin LJ, Blair C, Langley J, Hoeper MM; AMBITION Study Group.

J Heart Lung Transplant. 2019 Sep 17. pii: S1053-2498(19)31685-7. doi: 10.1016/j.healun.2019.09.010. [Epub ahead of print]

PMID:
31648845
4.

T Cell Repertoire Dynamics during Pregnancy in Multiple Sclerosis.

Ramien C, Yusko EC, Engler JB, Gamradt S, Patas K, Schweingruber N, Willing A, Rosenkranz SC, Diemert A, Harrison A, Vignali M, Sanders C, Robins HS, Tolosa E, Heesen C, Arck PC, Scheffold A, Chan K, Emerson RO, Friese MA, Gold SM.

Cell Rep. 2019 Oct 22;29(4):810-815.e4. doi: 10.1016/j.celrep.2019.09.025.

5.

Reciprocal space imaging of ionic correlations in intercalation compounds.

Krogstad MJ, Rosenkranz S, Wozniak JM, Jennings G, Ruff JPC, Vaughey JT, Osborn R.

Nat Mater. 2019 Oct 21. doi: 10.1038/s41563-019-0500-7. [Epub ahead of print] Erratum in: Nat Mater. 2019 Oct 30;:.

PMID:
31636421
6.

Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease.

Canepa M, Franssen FME, Olschewski H, Lainscak M, Böhm M, Tavazzi L, Rosenkranz S.

JACC Heart Fail. 2019 Oct;7(10):823-833. doi: 10.1016/j.jchf.2019.05.009. Epub 2019 Sep 11. Review.

PMID:
31521680
7.

Clinical outcomes stratified by baseline functional class after initial combination therapy for pulmonary arterial hypertension.

White RJ, Vonk-Noordegraaf A, Rosenkranz S, Oudiz RJ, McLaughlin VV, Hoeper MM, Grünig E, Ghofrani HA, Chakinala MM, Barberà JA, Blair C, Langley J, Frost AE.

Respir Res. 2019 Sep 12;20(1):208. doi: 10.1186/s12931-019-1180-1.

8.

Pharmacokinetics and Pharmacodynamics of Depot Medroxyprogesterone Acetate (DMPA) in African women receiving treatment for HIV and TB: Potential concern for standard dosing frequency.

Mngqibisa R, Kendall MA, Dooley K, Wu X, Firnhaber C, McIlleron H, Robinson J, Cramer Y, Rosenkranz SL, Roa J, Coughlin K, Mawlana S, Badal-Faesen S, Schnabel D, Omoz-Oarhe A, Samaneka W, Godfrey C, Cohn SE; A5338 study team.

Clin Infect Dis. 2019 Sep 5. pii: ciz863. doi: 10.1093/cid/ciz863. [Epub ahead of print]

PMID:
31504342
9.

Antiretroviral therapy and vaginally administered contraceptive hormones: a three-arm, pharmacokinetic study.

Scarsi KK, Cramer YS, Rosenkranz SL, Aweeka F, Berzins B, Coombs RW, Coughlin K, Moran LE, Zorrilla CD, Akelo V, Aziz M, Friedman RK, Gingrich D, Swaminathan S, Godfrey C, Cohn SE; AIDS Clinical Trials Group A5316 Study Team.

Lancet HIV. 2019 Sep;6(9):e601-e612. doi: 10.1016/S2352-3018(19)30155-9.

PMID:
31498109
10.

Cardiopulmonary interaction in heart or lung disease: physiology, disturbances, and their clinical implications.

Rosenkranz S, Bauersachs J.

Herz. 2019 Sep;44(6):475-476. doi: 10.1007/s00059-019-4832-5. No abstract available.

PMID:
31485719
11.

Spin Stripe Order in a Square Planar Trilayer Nickelate.

Zhang J, Pajerowski DM, Botana AS, Zheng H, Harriger L, Rodriguez-Rivera J, Ruff JPC, Schreiber NJ, Wang B, Chen YS, Chen WC, Norman MR, Rosenkranz S, Mitchell JF, Phelan D.

Phys Rev Lett. 2019 Jun 21;122(24):247201. doi: 10.1103/PhysRevLett.122.247201.

PMID:
31322403
12.

Pulmonary hypertension in HFpEF and HFrEF: Pathophysiology, diagnosis, treatment approaches.

Rosenkranz S, Kramer T, Gerhardt F, Opitz C, Olsson KM, Hoeper MM.

Herz. 2019 Sep;44(6):483-490. doi: 10.1007/s00059-019-4831-6.

PMID:
31317203
13.

Pulmonary hypertension and valvular heart disease.

Tichelbäcker T, Dumitrescu D, Gerhardt F, Stern D, Wissmüller M, Adam M, Schmidt T, Frerker C, Pfister R, Halbach M, Baldus S, Rosenkranz S.

Herz. 2019 Sep;44(6):491-501. doi: 10.1007/s00059-019-4823-6. Review.

PMID:
31312873
14.

Rosenkranz, Osborn, and Van Wezel Reply.

Rosenkranz S, Osborn R, van Wezel J.

Phys Rev Lett. 2019 Jun 7;122(22):229702. doi: 10.1103/PhysRevLett.122.229702. No abstract available.

PMID:
31283286
15.

[Hemodynamic Definition of Pulmonary Hypertension: Commentary on the Proposed Change by the 6th World Symposium on Pulmonary Hypertension].

Rosenkranz S, Diller GP, Dumitrescu D, Ewert R, Ghofrani HA, Grünig E, Halank M, Held M, Kaemmerer H, Klose H, Kovacs G, Konstantinides S, Lang IM, Lange TJ, Leuchte H, Mayer E, Olschewski A, Olschewski H, Olsson KM, Opitz C, Schermuly RT, Seeger W, Wilkens H, Hoeper MM.

Dtsch Med Wochenschr. 2019 Sep;144(19):1367-1372. doi: 10.1055/a-0918-3772. Epub 2019 Jul 5. German.

16.

Salivary Cystatin SN Binds to Phytic Acid In Vitro and Is a Predictor of Nonheme Iron Bioavailability with Phytic Acid Supplementation in a Proof of Concept Pilot Study.

Delimont NM, Katz BB, Fiorentino NM, Kimmel KA, Haub MD, Rosenkranz SK, Tomich JM, Lindshield BL.

Curr Dev Nutr. 2019 Apr 20;3(7):nzz057. doi: 10.1093/cdn/nzz057. eCollection 2019 Jul.

17.

The Emperor's New Clothes: Prospective Observational Evaluation of the Association between Initial Vancomycin Exposure and Failure Rates among Adult Hospitalized Patients with MRSA Bloodstream Infections (PROVIDE).

Lodise TP, Rosenkranz SL, Finnemeyer M, Evans S, Sims M, Zervos MJ, Creech CB, Patel PC, Keefer M, Riska P, Silveira FP, Scheetz M, Wunderink RG, Rodriguez M, Schrank J, Bleasdale SC, Schultz S, Barron M, Stapleton A, Wray D, Chambers H, Fowler V, Holland TL; Antibacterial Resistance Leadership Group.

Clin Infect Dis. 2019 Jun 3. pii: ciz460. doi: 10.1093/cid/ciz460. [Epub ahead of print]

PMID:
31157370
18.

Antiretroviral Activity of AMD11070 (An Orally Administered CXCR4 Entry Inhibitor): Results of NIH/NIAID AIDS Clinical Trials Group Protocol A5210.

Johnson VA, Cramer YS, Rosenkranz SL, Becker S, Klingman KL, Kallungal B, Coakley E, Acosta EP, Calandra G, Saag MS; NIH/NIAID AIDS Clinical Trials Group A5210 Protocol Team.

AIDS Res Hum Retroviruses. 2019 Aug;35(8):691-697. doi: 10.1089/AID.2018.0256. Epub 2019 Jun 18.

PMID:
31099252
19.

Bassoon proteinopathy drives neurodegeneration in multiple sclerosis.

Schattling B, Engler JB, Volkmann C, Rothammer N, Woo MS, Petersen M, Winkler I, Kaufmann M, Rosenkranz SC, Fejtova A, Thomas U, Bose A, Bauer S, Träger S, Miller KK, Brück W, Duncan KE, Salinas G, Soba P, Gundelfinger ED, Merkler D, Friese MA.

Nat Neurosci. 2019 Jun;22(6):887-896. doi: 10.1038/s41593-019-0385-4. Epub 2019 Apr 22.

PMID:
31011226
20.

Diagnosis of pulmonary hypertension using spectral-detector CT.

Kröger JR, Gerhardt F, Dumitrescu D, Rosenkranz S, Schmidt M, Maintz D, Bunck AC.

Int J Cardiol. 2019 Jun 15;285:80-85. doi: 10.1016/j.ijcard.2019.03.018. Epub 2019 Mar 13.

PMID:
30905521
21.

Key inflammatory pathways underlying vascular remodeling in pulmonary hypertension.

Berghausen EM, Feik L, Zierden M, Vantler M, Rosenkranz S.

Herz. 2019 Apr;44(2):130-137. doi: 10.1007/s00059-019-4795-6.

PMID:
30847510
22.

Sources of Variability and Accuracy of Performance Assessment in the Clinical Pharmacology Quality Assurance Proficiency Testing Program for Antiretrovirals.

Browne RW, Rosenkranz SL, Wang Y, Taylor CR, DiFrancesco R, Morse GD.

Ther Drug Monit. 2019 Aug;41(4):452-458. doi: 10.1097/FTD.0000000000000612.

PMID:
30829950
23.

Therapeutic potential of phosphodiesterase type 5 inhibitors in heart failure with preserved ejection fraction and combined post- and pre-capillary pulmonary hypertension.

Kramer T, Dumitrescu D, Gerhardt F, Orlova K, Ten Freyhaus H, Hellmich M, Baldus S, Rosenkranz S.

Int J Cardiol. 2019 May 15;283:152-158. doi: 10.1016/j.ijcard.2018.12.078. Epub 2019 Jan 4.

PMID:
30777406
24.

High-risk pregnancy in a patient with pulmonary arterial hypertension due to congenital heart disease (PAH-CHD) with temporary shunt inversion and deoxygenation.

Hohmann C, Dumitrescu D, Gerhardt F, Kramer T, Rosenkranz S, Huntgeburth M.

Pulm Circ. 2019 Apr-Jun;9(2):2045894019835649. doi: 10.1177/2045894019835649.

25.

Short-term interval aerobic exercise training does not improve memory functioning in relapsing-remitting multiple sclerosis-a randomized controlled trial.

Baquet L, Hasselmann H, Patra S, Stellmann JP, Vettorazzi E, Engel AK, Rosenkranz SC, Poettgen J, Gold SM, Schulz KH, Heesen C.

PeerJ. 2018 Dec 12;6:e6037. doi: 10.7717/peerj.6037. eCollection 2018.

26.

Pulmonary hypertension due to left heart disease.

Vachiéry JL, Tedford RJ, Rosenkranz S, Palazzini M, Lang I, Guazzi M, Coghlan G, Chazova I, De Marco T.

Eur Respir J. 2019 Jan 24;53(1). pii: 1801897. doi: 10.1183/13993003.01897-2018. Print 2019 Jan.

27.

Pulmonary hypertension associated with left heart disease: Updated Recommendations of the Cologne Consensus Conference 2018.

Rosenkranz S, Lang IM, Blindt R, Bonderman D, Bruch L, Diller GP, Felgendreher R, Gerges C, Hohenforst-Schmidt W, Holt S, Jung C, Kindermann I, Kramer T, Kübler WM, Mitrovic V, Riedel A, Rieth A, Schmeisser A, Wachter R, Weil J, Opitz CF.

Int J Cardiol. 2018 Dec 1;272S:53-62. doi: 10.1016/j.ijcard.2018.08.080. Epub 2018 Aug 27. Review.

PMID:
30527996
28.

Driving following defibrillator implantation: development and pilot results from a nationwide questionnaire.

Bjerre J, Rosenkranz SH, Christensen AM, Schou M, Jøns C, Gislason G, Ruwald AC.

BMC Cardiovasc Disord. 2018 Nov 20;18(1):212. doi: 10.1186/s12872-018-0949-3.

29.

Cologne consensus conference on pulmonary hypertension - Update 2018.

Rosenkranz S, Ghofrani HA, Grünig E, Klose H, Olschewski H, Hoeper MM.

Int J Cardiol. 2018 Dec 1;272S:1-3. doi: 10.1016/j.ijcard.2018.09.064. Epub 2018 Sep 22. No abstract available.

PMID:
30344062
30.

Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients.

Delcroix M, Staehler G, Gall H, Grünig E, Held M, Halank M, Klose H, Vonk-Noordegraaf A, Rosenkranz S, Pepke-Zaba J, Opitz CF, Gibbs JSR, Lange TJ, Tsangaris I, Huscher D, Pittrow D, Olsson KM, Hoeper MM.

Eur Respir J. 2018 Nov 8;52(5). pii: 1800248. doi: 10.1183/13993003.00248-2018. Print 2018 Nov.

PMID:
30337446
31.

Long-term safety and outcome of intravenous treprostinil via an implanted pump in pulmonary hypertension.

Richter MJ, Harutyunova S, Bollmann T, Classen S, Gall H, Gerhardt Md F, Grimminger F, Grimminger J, Grünig E, Guth S, Halank M, Heine A, Hoeper MM, Klose H, Lange TJ, Meyer K, Neurohr C, Nickolaus K, Olsson KM, Opitz CF, Rosenkranz S, Seyfarth HJ, Warnke C, Wiedenroth C, Ghofrani HA, Ewert R.

J Heart Lung Transplant. 2018 Oct;37(10):1235-1244. doi: 10.1016/j.healun.2018.06.006. Epub 2018 Jun 21.

PMID:
30293617
32.

Impact of online, video-based wellness training on Girl Scout leaders' wellness promotion self-efficacy, intention, and knowledge: A pilot randomized controlled trial.

Cull BJ, Rosenkranz SK, Rosenkranz RR.

AIMS Public Health. 2018 Jul 6;5(3):225-234. doi: 10.3934/publichealth.2018.3.225. eCollection 2018.

33.

Riociguat for the Treatment of Raynaud's Phenomenon: A Single-Dose, Double-Blind, Randomized, Placebo-Controlled Cross-Over Pilot Study (DIGIT).

Huntgeburth M, Kießling J, Weimann G, Wilberg V, Saleh S, Hunzelmann N, Rosenkranz S.

Clin Drug Investig. 2018 Nov;38(11):1061-1069. doi: 10.1007/s40261-018-0698-1.

PMID:
30238433
34.

[Telemonitoring and pulmonary artery pressure-guided treatment of heart failure].

Angermann CE, Rosenkranz S.

Internist (Berl). 2018 Oct;59(10):1041-1053. doi: 10.1007/s00108-018-0495-1. Review. German.

PMID:
30238134
35.

Targeted therapy of pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018.

Hoeper MM, Apitz C, Grünig E, Halank M, Ewert R, Kaemmerer H, Kabitz HJ, Kähler C, Klose H, Leuchte H, Ulrich S, Olsson KM, Distler O, Rosenkranz S, Ghofrani HA.

Int J Cardiol. 2018 Dec 1;272S:37-45. doi: 10.1016/j.ijcard.2018.08.082. Epub 2018 Aug 25.

PMID:
30190158
36.

Variation in Nutritional Quality of School Lunches With Implementation of National School Lunch Program Guidelines.

Joyce JM, Rosenkranz RR, Rosenkranz SK.

J Sch Health. 2018 Sep;88(9):636-643. doi: 10.1111/josh.12665.

PMID:
30133780
37.

Many Kansas Worksites Offer Few Interventions to Reduce Occupational Sedentary Behavior.

Ablah E, Grilliot E, Okut H, Mailey EL, Rosenkranz SK, Rosenkranz RR.

Int J Environ Res Public Health. 2018 Aug 14;15(8). pii: E1745. doi: 10.3390/ijerph15081745.

38.

Right Heart Catheterization for the Diagnosis of Pulmonary Hypertension: Controversies and Practical Issues.

D'Alto M, Dimopoulos K, Coghlan JG, Kovacs G, Rosenkranz S, Naeije R.

Heart Fail Clin. 2018 Jul;14(3):467-477. doi: 10.1016/j.hfc.2018.03.011. Review.

PMID:
29966642
39.

Long-Term Dose-Response Condensed Tannin Supplementation Does Not Affect Iron Status or Bioavailability.

Delimont NM, Fiorentino NM, Kimmel KA, Haub MD, Rosenkranz SK, Lindshield BL.

Curr Dev Nutr. 2017 Sep 11;1(10):e001081. doi: 10.3945/cdn.117.001081. eCollection 2017 Oct.

40.

The relation of local order to material properties in relaxor ferroelectrics.

Krogstad MJ, Gehring PM, Rosenkranz S, Osborn R, Ye F, Liu Y, Ruff JPC, Chen W, Wozniak JM, Luo H, Chmaissem O, Ye ZG, Phelan D.

Nat Mater. 2018 Aug;17(8):718-724. doi: 10.1038/s41563-018-0112-7. Epub 2018 Jun 25.

PMID:
29941922
41.

Metabolomic Profiles for Primary Progressive Multiple Sclerosis Stratification and Disease Course Monitoring.

Stoessel D, Stellmann JP, Willing A, Behrens B, Rosenkranz SC, Hodecker SC, Stürner KH, Reinhardt S, Fleischer S, Deuschle C, Maetzler W, Berg D, Heesen C, Walther D, Schauer N, Friese MA, Pless O.

Front Hum Neurosci. 2018 Jun 4;12:226. doi: 10.3389/fnhum.2018.00226. eCollection 2018.

42.

Phase I Study To Evaluate the Pharmacokinetics, Safety, and Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Participants.

Wenzler E, Bleasdale SC, Sikka M, Bunnell KL, Finnemeyer M, Rosenkranz SL, Danziger LH, Rodvold KA; Antibacterial Resistance Leadership Group.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00464-18. doi: 10.1128/AAC.00464-18. Print 2018 Aug.

43.

Myeloperoxidase aggravates pulmonary arterial hypertension by activation of vascular Rho-kinase.

Klinke A, Berghausen E, Friedrichs K, Molz S, Lau D, Remane L, Berlin M, Kaltwasser C, Adam M, Mehrkens D, Mollenhauer M, Manchanda K, Ravekes T, Heresi GA, Aytekin M, Dweik RA, Hennigs JK, Kubala L, Michaëlsson E, Rosenkranz S, Rudolph TK, Hazen SL, Klose H, Schermuly RT, Rudolph V, Baldus S.

JCI Insight. 2018 Jun 7;3(11). pii: 97530. doi: 10.1172/jci.insight.97530. eCollection 2018 Jun 7.

44.

Safety and feasibility of pulmonary artery pressure-guided heart failure therapy: rationale and design of the prospective CardioMEMS Monitoring Study for Heart Failure (MEMS-HF).

Angermann CE, Assmus B, Anker SD, Brachmann J, Ertl G, Köhler F, Rosenkranz S, Tschöpe C, Adamson PB, Böhm M.

Clin Res Cardiol. 2018 Nov;107(11):991-1002. doi: 10.1007/s00392-018-1281-8. Epub 2018 May 19.

PMID:
29777373
45.

Implementation of cross correlation for energy discrimination on the time-of-flight spectrometer CORELLI.

Ye F, Liu Y, Whitfield R, Osborn R, Rosenkranz S.

J Appl Crystallogr. 2018 Mar 26;51(Pt 2):315-322. doi: 10.1107/S160057671800403X. eCollection 2018 Apr 1.

46.

Risk assessment in pulmonary arterial hypertension.

Hoeper MM, Pittrow D, Opitz C, Gibbs JSR, Rosenkranz S, Grünig E, Olsson KM, Huscher D.

Eur Respir J. 2018 Mar 29;51(3). pii: 1702606. doi: 10.1183/13993003.02606-2017. Print 2018 Mar. No abstract available.

47.

Wellness-Promoting Practices Through Girl Scouts: A Pragmatic Superiority Randomized Controlled Trial With Additional Dissemination.

Cull BJ, Dzewaltowski DA, Guagliano JM, Rosenkranz SK, Knutson CK, Rosenkranz RR.

Am J Health Promot. 2018 Sep;32(7):1544-1554. doi: 10.1177/0890117118754825. Epub 2018 Jan 29.

PMID:
29378416
48.

Coherent band excitations in CePd3: A comparison of neutron scattering and ab initio theory.

Goremychkin EA, Park H, Osborn R, Rosenkranz S, Castellan JP, Fanelli VR, Christianson AD, Stone MB, Bauer ED, McClellan KJ, Byler DD, Lawrence JM.

Science. 2018 Jan 12;359(6372):186-191. doi: 10.1126/science.aan0593.

PMID:
29326267
49.

Postprandial Metabolic Responses Differ by Age Group and Physical Activity Level.

Emerson SR, Kurti SP, Emerson EM, Cull BJ, Casey K, Haub MD, Rosenkranz SK.

J Nutr Health Aging. 2018;22(1):145-153. doi: 10.1007/s12603-017-0956-6.

PMID:
29300434
50.

Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study.

McLaughlin VV, Jansa P, Nielsen-Kudsk JE, Halank M, Simonneau G, Grünig E, Ulrich S, Rosenkranz S, Gómez Sánchez MA, Pulido T, Pepke-Zaba J, Barberá JA, Hoeper MM, Vachiéry JL, Lang I, Carvalho F, Meier C, Mueller K, Nikkho S, D'Armini AM.

BMC Pulm Med. 2017 Dec 28;17(1):216. doi: 10.1186/s12890-017-0563-7.

Supplemental Content

Loading ...
Support Center